Ebola Treatment Shown to Work on Infected Monkeys

Global Security Newswire Staff
Add to Briefcase
See more stories about...
Global Security Newswire Staff
Aug. 22, 2013, 9:02 a.m.

A new Ebola drug grown from spe­cial to­bacco plants has been shown to cure mon­keys that were already dis­play­ing signs of in­fec­tion by the vir­al hem­or­rhagic fever, the Los Angeles Times re­por­ted on Wed­nes­day.

Oth­er Ebola coun­ter­meas­ures have been shown to work on in­fec­ted an­im­als be­fore they start dis­play­ing symp­toms of the highly vir­u­lent and leth­al dis­ease. However, this is the first time a drug has demon­strated any ef­fect­ive­ness after signs of the vir­us have mani­fes­ted. That is re­garded as a cru­cial cap­ab­il­ity in the event of a real-life dis­ease epi­dem­ic, ac­cord­ing to vir­o­lo­gist Gene Olinger, who works at the Army Med­ic­al Re­search In­sti­tute of In­fec­tious Dis­eases at Fort De­t­rick, Md.

“We’ve pushed the op­por­tun­ity to treat people to the point where they walk in and say, ‘I have a fever,’” said Olinger, co-au­thor of a re­port on the new Ebola drug pub­lished by the Sci­ence Trans­la­tion­al Medi­cine journ­al on Wed­nes­day. “A lot of folks in the field would have thought pro­tect­ing an an­im­al at the time of fever and viremia is too late to have a clin­ic­al be­ne­fit.”

Ebola is one of the most deadly and con­ta­gious dis­eases known to ex­ist in nature. The lack of ad­equate vac­cines and an­ti­dotes for the dis­ease have made it a ser­i­ous worry for biode­fense spe­cial­ists con­cerned about its pos­sible ap­plic­a­tions as a bio­lo­gic­al weapon.

In the re­cent study, sev­en in­fec­ted rhesus mon­keys were ad­min­istered the ex­per­i­ment­al treat­ment MB-003 through their veins once every three days. Three of the mon­keys did not die, res­ult­ing in a stat­ist­ic­ally not­able suc­cess rate of 43 per­cent.

Fort De­t­rick sci­ent­ist and lead study au­thor James Pet­titt said it is prob­able that in a real-life out­break, the drug would be ad­min­istered at a high­er dosage and with great­er fre­quency.

“We think we’ll get bet­ter res­ults,” the re­search­er said.

Grow­ing the drug from spe­cially de­veloped to­bacco leaves is not only less costly than con­ven­tion­al cell-based meth­ods, but also al­lows for large batches of the drug to be pro­duced on fairly short, weeklong sched­ules, ac­cord­ing to the Times art­icle.

Olinger said fur­ther meas­ures will be taken to im­prove MB-003 by adding to it more Ebola an­ti­bod­ies that were dis­covered by a dif­fer­ent group of re­search­ers.

What We're Following See More »
HALF OF 2016 LEVELS
Hiring of Deportation Officers Drops Under Trump
2 hours ago
THE DETAILS

"The Trump administration is failing to hire law enforcement personnel to enforce immigration laws despite a significant push to do so, according to new Homeland Security Department documents. The hiring of new deportation officers at Immigration and Customs Enforcement dropped in half to just 371 total in 2017, according to information provided to potential vendors for a contract to help ICE boost hiring."

Source:
HEARING THIS AFTERNOON
Mueller Indicts Attorney for Making False Statements About Gates
4 hours ago
THE LATEST
THE QUESTION
What’s the Value of Suspicious Transactions by Paul Manafort that Mueller Is Investigating?
4 hours ago
THE ANSWER

About $40 million, "a much larger sum than was cited in his October indictment on money laundering charges."

Source:
SHOW OF FORCE TO MOSCOW
Two U.S. Navy Destroyers Operating in Black Sea
4 hours ago
THE DETAILS

"Under cover of darkness, U.S. Navy guided-missile destroyer USS Ross (DDG-71) slipped through the Bosporus Strait and into the Black Sea on Friday. The next day USS Carney (DDG-64) joined Ross. The ships are operating are part of an unspecified regional “proactive” presence mission in the sea bordered by Russia, according to the Navy."

Source:
CHINESE INVESTORS AS WELL AS RUSSIANS
Mueller Looking into Kushner Finances
16 hours ago
THE LATEST

"Special counsel Robert Mueller's interest in Jared Kushner has expanded beyond his contacts with Russia and now includes his efforts to secure financing for his company from foreign investors during the presidential transition, according to people familiar with the inquiry. This is the first indication that Mueller is exploring Kushner's discussions with potential non-Russian foreign investors, including in China." At issue specifically is his quest for financing help on the beleaguered 666 Fifth Avenue building.

Source:
×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login